NOTICE OF JUDGMENT NO. 2540.
(Given pursuant to section 4 of. the Food and Drugs Act.)
V. S. v. Ungerer & Co. (Inc.).    Plea of guilty.    Fine, $10.
ADULTERATION AND MISBRANDING OF OIL OF CASSIA.
On March 5, 1913, the United States Attorney for the Southern 
District of New York, acting upon a report by the Secretary of Agri- 
culture, filed in the District Court of the United States for said dis- 
trict an information against Ungerer & Co. (Inc.), a corporation, 
New York, N. Y., alleging shipment by said company, in violation of 
the Food and Drugs Act, on March 1, 1912, from the State of New 
York into the State of Texas of a quantity of oil of cassia which was 
adulterated and misbranded. The product was labeled: " Oil of 
cassia 75-80 per cent. in. Aid. Ungerer & Co., New York, Tech- 
nical Guaranteed by Ungerer & Co. under Food & Drugs Act of June 
30, 1906.    Serial No. 521.    1 lb."
An analysis of a sample of the product made by the Bureau of 
Chemistry of this Department showed the following results: Specific 
gravity at 25° C, 1.0579; refruitive index at 20° C, 1.5978; optical 
rotation 100 mm 20° O, +5.41°; soluble in 2 volumes of 70 per cent 
alcohol; resins present (large amount) ; copper acetate test, positive; 
lead acetate test, positive; lead present (large amount) ; cinnamic 
aldehyde (by absorption) (per cent), 69.5. Oil is not U. S. P. High 
rotation. Lead and resins or resin present. Adulteration of the 
product was alleged in the information for the reason that it was 
sold under and by a name recognized in the United States Pharma- 
copoeia, to wit, oil of cassia, and it differed from the standard of 
strength, quality, and purity as determined by the test laid down in
10453°—No. 2540—13
said Pharmacopoeia official at the time of said shipment and investi- 
gation, in that the specific gravity of said drug at 25° C. was above 
1.055, and was in fact 1.058, whereas said Pharmacopoeia provides as 
a test for oil of cassia that a specific gravity at 25° C. shall be between 
1.045 and 1.055; and further, in that the rotation of said drug was 
more than 1? and was in fact 5.4?, whereas the said Pharmacopoeia 
provides that the rotation of said drug shall not be more than 1°, 
and said drug contained less than 75 per cent by volume of cinnamic 
aldehyde, and in fact contained 69.5 per cent, whereas said Phar- 
macopoeia provides that oil of cassia shall contain not less than 75 
per cent by volume of cinnamic aldehyde; and further in that said 
drug contained lead and resin, which are not ingredients of oil of 
cassia as determined by the test laid down in said Pharmacopoeia. 
Adulteration of the product was alleged for the further reason that 
other substances, to wit, resin and lead, were mixed and packed there- 
with in such a manner as to reduce, lower, and injuriously affect its 
quality and strength; and further in that other substances, to wit, 
resin and lead, had been substituted in part for the genuine article, 
oil of cassia, and in that the product contained an added poisonous 
and deleterious ingredient which might render it injurious to health, 
to wit, lead. Misbranding was alleged for the reason that the product 
was labeled as set forth above, so as to deceive and mislead the pur- 
chaser thereof, in that said label would indicate that said drug was 
true oil of cassia, whereas, in truth and in fact, the said drug was 
crude oil of cassia containing added resin and lead, and in that the 
label would indicate that said drug contained between 75 per cent 
and 80 per cent of cinnamic aldehyde, whereas, in truth and in fact, it 
contained only 69.5 per cent cinnamic aldehyde.
On March 17, 1913, the defendant company entered a plea of 
guilty to the information and the court imposed a fine of $10.
B. T. GALLOWAY,
Acting Secretary of Agriculture.
WASHINGTON, D. C, August 26,1913.
2540
o